OBJECTIVES:
The purpose of this study was to evaluate supply cost differences and clinical outcomes with and without the intrauterine morcellator, and to determine predictors of its use for hysteroscopic polypectomy. MATERIALS AND METHODS: Hysteroscopic polypectomy cases performed at two hospitals in southwest Ohio between January 2013 and October 2017 were included. Patient and surgeon characteristics, surgical outcomes, and follow-up data were obtained from chart review. Categorical variables were analyzed using Chi-square while T-test or Wilcoxon Rank Sum were used for the continuous variables as appropriate. Logistic regression was used to model variables predicting morcellator use. RESULTS: The sample included 260 hysteroscopic polypectomies performed by 14 surgeons. Of these, 174 (67%) used the morcellator and 86 (33%) did not. The study variable most predictive of morcellator use was surgeon identity. Supply cost with morcellator use was significantly greater than for cases without morcellator use ($1451 vs. $188, p<0.001). Operating room times were similar between groups (60 vs. 58 minutes, p¼0.67). Pathologic specimen volumes were greater with the morcellator among premenopausal women (median 2.2 cm 3 vs. 1.6 cm 3 , p¼0.03), but no difference was identified among postmenopausal women (2.6 cm 3 vs. 1.9 cm 3 , p¼0.11). Rates of persistent or recurrent abnormal uterine bleeding (AUB) within one year following polypectomy were similar between groups (12% vs. 20%, p¼0.08), and rates of subsequent procedures for management of bleeding were also similar (4.3% vs. 8.8%, p¼0.17). CONCLUSION: A large cost differential exists between hysteroscopic polypectomy using the intrauterine morcellator versus mechanical tissue removal. While among premenopausal women more tissue was recovered, this was not true among postmenopausal women. Persistent or recurrent AUB was similar irrespective of technique. Surgeon identity was the most predictive factor of morcellator use. These findings suggest use of the intrauterine morcellator for polypectomy is low value and influencing surgeon behavior may help to increase cost-effectiveness with this procedure for this indication. 
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:

OBJECTIVES:
The objective of this study was to evaluate the incidence of and risk factors for early small bowel obstruction (SBO), occurring within the first month of surgery, after benign hysterectomy.
MATERIALS AND METHODS:
This was a retrospective cohort study using data from the American College of Surgeons National Surgical Quality Improvement Program database from 2014 to 2016. Current Procedural Terminology codes were used to identify patients undergoing hysterectomy for benign indications with or without concomitant colpopexy, lysis of adhesions (LOA), adnexectomy, or appendectomy. Patient demographics, clinical and surgical factors were obtained. Patients were then stratified into those with and without and SBO. Differences between groups were evaluated using Chi-squared and Fisher's exact tests for categorical variables, and the Student's t-test for continuous variables. Multivariable logistic regression was used to identify significant independent predictors of SBO.
ajog.org
Non-Oral Posters
Supplement to MARCH 2019 American Journal of Obstetrics & Gynecology S727
